Zuranolone for treating postpartum depression
The US FDA (Food and Drug Administration) has approved the use of zuranolone for the treatment of postpartum depression in the USA. According to the data, a significant improvement is expected after the third day of treatment. Noelia Extremera, the psychologist specializing in perinatal mental health at LactApp, reflects on this news and the impact of treating the consequences and not the causes of a situation that pathologizes mothers. Problem solved, isn’t it? Women have an unrecognized but fundamental role…